{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:15:34Z","timestamp":1789578934478,"version":"build-2803163510"},"reference-count":181,"publisher":"The Endocrine Society","issue":"3","license":[{"start":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T00:00:00Z","timestamp":1763164800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Increased serum calcium with elevated or nonsuppressed PTH levels is the biochemical hallmark of primary hyperparathyroidism (PHPT). A large body of evidence linked both hypercalcemia and high serum levels of PTH with cardiovascular diseases, due to their actions on cardiomyocytes, endothelial, pancreatic \u03b2, and fat cells. However, controversial epidemiological data exist regarding the higher prevalence of hypertension, arrhythmias, dyslipidemia, echocardiographic, and vascular parameter impairments in PHPT patients compared to controls. Different cardiovascular risk factors related to sex, age groups, serum calcium levels, and different countries included in these studies cause conflicting results.<\/jats:p>\n                  <jats:p>Although current guidelines on hypercalcemic PHPT management do not suggest parathyroidectomy based on cardiovascular diseases, one meta-analysis showed improvement following parathyroidectomy for glucose metabolism and reduction of blood pressure. While structural cardiac changes such as left ventricular mass index was improved following parathyroidectomy in one but not in another meta-analysis, a more modern method that included global longitudinal strain measurement of left ventricular mass showed improvement following parathyroidectomy.<\/jats:p>\n                  <jats:p>An increased risk of major cerebrovascular or cardiovascular events in PHPT patients compared to controls has been reported in some but not all studies. Furthermore, meta-analyses are not always consistent in showing a higher risk of total and cardiovascular death in PHPT patients compared to the general population, as well as their reduction following parathyroidectomy.<\/jats:p>\n                  <jats:p>Robust randomized controlled studies are needed to definitively answer whether in patients with PHPT cardiovascular disease depend on serum calcium levels, PTH, or both, thus representing another new criterion to submit patients to surgery.<\/jats:p>","DOI":"10.1210\/clinem\/dgaf625","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T13:02:54Z","timestamp":1763038974000},"page":"603-614","source":"Crossref","is-referenced-by-count":8,"title":["Cardiovascular Involvement in Primary Hyperparathyroidism"],"prefix":"10.1210","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3088-0673","authenticated-orcid":false,"given":"Jessica","family":"Pepe","sequence":"first","affiliation":[{"name":"Department of Medical and Cardiovascular Sciences, \u201cSapienza\u201d University , Rome 00161 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6525-0439","authenticated-orcid":false,"given":"Salvatore","family":"Minisola","sequence":"additional","affiliation":[{"name":"Department of Medical and Cardiovascular Sciences, \u201cSapienza\u201d University , Rome 00161 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evaristo","family":"Ettorre","sequence":"additional","affiliation":[{"name":"Department of Medical and Cardiovascular Sciences, \u201cSapienza\u201d University , Rome 00161 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovambattista","family":"Desideri","sequence":"additional","affiliation":[{"name":"Department of Medical and Cardiovascular Sciences, \u201cSapienza\u201d University , Rome 00161 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Cipriani","sequence":"additional","affiliation":[{"name":"Department of Medical and Cardiovascular Sciences, \u201cSapienza\u201d University , Rome 00161 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"issue":"11","key":"2026021918532649300_dgaf625-B1","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1002\/jbmr.4665","article-title":"Epidemiology, pathophysiology, and genetics of primary hyperparathyroidism","volume":"37","author":"Minisola","year":"2022","journal-title":"J Bone Miner Res"},{"key":"2026021918532649300_dgaf625-B2","doi-asserted-by":"crossref","first-page":"115812","DOI":"10.1016\/j.amjsurg.2024.115812","article-title":"Normocalcemic primary hyperparathyroidism: from pathophysiology to clinical management","volume":"235","author":"Wu","year":"2024","journal-title":"Am J Surg"},{"issue":"7","key":"2026021918532649300_dgaf625-B3","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.tem.2024.02.005","article-title":"Towler parathyroid hormone-PTH1R signaling in cardiovascular disease and homeostasis","volume":"35","author":"Dwight","year":"2024","journal-title":"Trends Endocrinol Metab"},{"issue":"4","key":"2026021918532649300_dgaf625-B4","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/CRD.0000000000000250","article-title":"Parathyroid hormone and cardiac electrophysiology: a review","volume":"27","author":"Palmeri","year":"2019","journal-title":"Cardiol Rev"},{"key":"2026021918532649300_dgaf625-B5","first-page":"233","article-title":"Electrolyte disorders and arrhythmogenesis","volume":"18","author":"El-Sherif","year":"2011","journal-title":"Cardiol J"},{"issue":"2","key":"2026021918532649300_dgaf625-B6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11914-008-0014-8","article-title":"Parathyroid hormone and the cardiovascular system","volume":"6","author":"Fitzpatrick","year":"2008","journal-title":"Curr Osteoporos Rep"},{"issue":"2","key":"2026021918532649300_dgaf625-B7","doi-asserted-by":"crossref","first-page":"101980","DOI":"10.1016\/j.beem.2025.101980","article-title":"Bhadada SK changing trends in clinical presentation of primary hyperparathyroidism across countries over time","volume":"39","author":"Arjunan","year":"2025","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"20","key":"2026021918532649300_dgaf625-B8","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/j.ehj.2004.07.010","article-title":"Primary hyperparathyroidism and heart disease-a review","volume":"25","author":"Andersson","year":"2004","journal-title":"Eur Heart J"},{"issue":"10","key":"2026021918532649300_dgaf625-B9","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/BF03346443","article-title":"Cardiovascular aspects of primary hyperparathyroidism","volume":"31","author":"Walker","year":"2008","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"2026021918532649300_dgaf625-B10","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.beem.2018.06.006","article-title":"Non classical complications of primary hyperparathyroidism","volume":"32","author":"Chiodini","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"11","key":"2026021918532649300_dgaf625-B11","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1002\/jbmr.4679","article-title":"Classical and nonclassical manifestations of primary hyperparathyroidism","volume":"37","author":"El-Hajj Fuleihan","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2026021918532649300_dgaf625-B12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cnur.2006.11.010","article-title":"Primary hyperparathyroidism, insulin resistance, and cardiovascular disease: a review","volume":"42","author":"Ybarra","year":"2007","journal-title":"Nur Clin North Am"},{"issue":"6","key":"2026021918532649300_dgaf625-B13","doi-asserted-by":"crossref","first-page":"R297","DOI":"10.1530\/EJE-17-0485","article-title":"Cardiovascular manifestations of primary hyperparathyroidism: a narrative review","volume":"177","author":"Pepe","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2026021918532649300_dgaf625-B14","doi-asserted-by":"crossref","first-page":"136","DOI":"10.21037\/gs.2019.12.12","article-title":"The role of parathyroidectomy in treating hypertension and other cardiac manifestations of primary hyperparathyroidism","volume":"9","author":"Nelson","year":"2020","journal-title":"Gland Surg"},{"key":"2026021918532649300_dgaf625-B15","first-page":"100317","article-title":"Symptomatic versus asymptomatic primary hyperparathyroidism: a systematic review and meta-analysis","volume":"32","author":"Kulkarni","year":"2023","journal-title":"J Clin Transl Endocrinol"},{"issue":"1","key":"2026021918532649300_dgaf625-B16","doi-asserted-by":"crossref","first-page":"142","DOI":"10.21037\/gs.2019.10.21","article-title":"Primary hyperparathyroidism and hypertension","volume":"9","author":"Fisher","year":"2020","journal-title":"Gland Surg"},{"issue":"43","key":"2026021918532649300_dgaf625-B17","doi-asserted-by":"crossref","first-page":"5628","DOI":"10.2174\/1381612824999201105165642","article-title":"Cardiovascular risk in patients with primary hyperparathyroidism","volume":"26","author":"Tournis","year":"2020","journal-title":"Curr Pharm Des"},{"key":"2026021918532649300_dgaf625-B18","doi-asserted-by":"crossref","first-page":"117130","DOI":"10.1016\/j.bone.2024.117130","article-title":"Association between primary hyperparathyroidism and cardiovascular outcomes: a systematic review and meta-analysis","volume":"185","author":"Kong","year":"2024","journal-title":"Bone"},{"issue":"1","key":"2026021918532649300_dgaf625-B19","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s12020-020-02519-7","article-title":"The influence of parathyroidectomy on cardiometabolic risk factors in patients with primary hyperparathyroidism: a systematic review and meta-analysis","volume":"72","author":"Yavari","year":"2021","journal-title":"Endocrine"},{"issue":"7","key":"2026021918532649300_dgaf625-B20","doi-asserted-by":"crossref","first-page":"103850","DOI":"10.1016\/j.numecd.2025.103850","article-title":"Effect of surgical treatment on left ventricular strain in patients with primary hyperparathyroidism: a meta-analysis of echocardiographic study","volume":"35","author":"Gherbesi","year":"2025","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"6","key":"2026021918532649300_dgaf625-B21","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1210\/clinem\/dgab157","article-title":"Meta-analysis on the effect of mild primary hyperparathyroidism and parathyroidectomy upon arterial stiffness","volume":"106","author":"Bernardi","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2026021918532649300_dgaf625-B22","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1210\/jc.2015-3202","article-title":"Effect of parathyroidectomy upon left ventricular mass in primary hyperparathyroidism: a meta-analysis","volume":"100","author":"McMahon","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2026021918532649300_dgaf625-B23","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/jbmr.4677","article-title":"International workshop on primary hyperparathyroidism. Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth international workshop","volume":"37","author":"Bilezikian","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"12","key":"2026021918532649300_dgaf625-B24","doi-asserted-by":"crossref","first-page":"e2248332","DOI":"10.1001\/jamanetworkopen.2022.48332","article-title":"Analysis of time to diagnosis and outcomes among adults with primary hyperparathyroidism","volume":"5","author":"Lorenz","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"1","key":"2026021918532649300_dgaf625-B25","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1001\/jamasurg.2019.3950","article-title":"Parathyroidectomy for patients with primary hyperparathyroidism and associations with hypertension","volume":"155","author":"Graff-Baker","year":"2020","journal-title":"JAMA Surg"},{"issue":"11","key":"2026021918532649300_dgaf625-B26","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/sj.jhh.1001907","article-title":"Ambulatory monitoring of blood pressure (AMBP) in patients with primary hyperparathyroidism","volume":"19","author":"Letizia","year":"2005","journal-title":"J Hum Hypertens"},{"issue":"3","key":"2026021918532649300_dgaf625-B27","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/hr.2010.232","article-title":"Pulse wave velocity in primary hyperparathyroidism and effect of surgical therapy","volume":"34","author":"Rosa","year":"2011","journal-title":"Hyperten Res"},{"issue":"3","key":"2026021918532649300_dgaf625-B28","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00774-015-0673-3","article-title":"Normocalcemic hyperparathyroidism is associated with complications similar to those of hypercalcemic hyperparathyroidism","volume":"34","author":"Tuna","year":"2016","journal-title":"J Bone Miner Metab"},{"issue":"2","key":"2026021918532649300_dgaf625-B29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1507\/endocrj.EJ15-0392","article-title":"Patients with normocalcemic primary hyperparathyroidism may have similar metabolic profile as hypercalcemic patients","volume":"63","author":"Ozturk","year":"2016","journal-title":"Endocr J"},{"issue":"6","key":"2026021918532649300_dgaf625-B30","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1210\/jc.2014-4432","article-title":"Is normocalcemic primary hyperparathyroidism harmful or harmless?","volume":"100","author":"Chen","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026021918532649300_dgaf625-B31","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1007\/s12020-024-04063-0","article-title":"Normocalcemic primary hyperparathyroidism is not associated with cardiometabolic alterations","volume":"86","author":"Barale","year":"2024","journal-title":"Endocrine"},{"issue":"1","key":"2026021918532649300_dgaf625-B32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4158\/EP-2020-0405","article-title":"Echocardiographic findings in patients with normocalcemic primary hyperparathyroidism compared with findings in hypercalcemic primary hyperparathyroid patients and control subjects","volume":"27","author":"Pepe","year":"2021","journal-title":"Endocr Pract"},{"issue":"6","key":"2026021918532649300_dgaf625-B33","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s40618-023-02264-4","article-title":"Twenty-four hour Holter ECG in normocalcemic and hypercalcemic patients with hyperparathyroidism","volume":"47","author":"Pepe","year":"2024","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2026021918532649300_dgaf625-B34","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12872-019-1093-4","article-title":"Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism","volume":"19","author":"Beysel","year":"2019","journal-title":"BMC Cardiovasc Disord"},{"issue":"6","key":"2026021918532649300_dgaf625-B35","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/cen.15118","article-title":"Higher risk of incident diabetes among patients with primary hyperparathyroidism","volume":"101","author":"Zhang","year":"2024","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2026021918532649300_dgaf625-B36","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4142\/jvs.2017.18.3.261","article-title":"Calcium homeostasis in diabetes mellitus","volume":"18","author":"Ahn","year":"2017","journal-title":"J Vet Sci"},{"issue":"11","key":"2026021918532649300_dgaf625-B37","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.2337\/db17-1351","article-title":"Impaired store-operated calcium entry and STIM1 loss lead to reduced insulin secretion and increased endoplasmic reticulum stress in the diabetic \u03b2-cell","volume":"67","author":"Kono","year":"2018","journal-title":"Diabetes"},{"issue":"10","key":"2026021918532649300_dgaf625-B38","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.2337\/db16-0084","article-title":"SERCA2 deficiency impairs pancreatic \u03b2-cell function in response to diet-induced obesity","volume":"65","author":"Tong","year":"2016","journal-title":"Diabetes"},{"issue":"11","key":"2026021918532649300_dgaf625-B39","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1053\/meta.2000.17708","article-title":"Insulin sensitivity is inversely correlated with plasma intact parathyroid hormone level","volume":"49","author":"Chiu","year":"2000","journal-title":"Metabolism"},{"issue":"9","key":"2026021918532649300_dgaf625-B40","first-page":"11964","article-title":"Glucose metabolic disorder in primary hyperparathyroidism: a systematic review and meta-analysis","volume":"12","author":"Sun","year":"2019","journal-title":"Int J Clin Exp Med"},{"issue":"21","key":"2026021918532649300_dgaf625-B41","doi-asserted-by":"crossref","first-page":"6718","DOI":"10.3390\/jcm12216718","article-title":"Primary hyperparathyroidism and cardiovascular disease: an association study using clinical natural language processing systems and big data analytics","volume":"12","author":"Iglesias","year":"2023","journal-title":"J Clin Med"},{"issue":"16","key":"2026021918532649300_dgaf625-B42","doi-asserted-by":"crossref","first-page":"1563967","DOI":"10.3389\/fimmu.2025.1563967","article-title":"Unravelling the link between chronic inflammation and primary hyperparathyroidism: a systematic review","volume":"2","author":"Gheorghe-Milea","year":"2025","journal-title":"Front Immunol"},{"issue":"3-4","key":"2026021918532649300_dgaf625-B43","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ando.2020.02.005","article-title":"PTH and cardiovascular risk","volume":"82","author":"Gruson","year":"2021","journal-title":"Ann. Endocrinol"},{"issue":"1","key":"2026021918532649300_dgaf625-B44","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s12020-024-04141-3","article-title":"Characteristics of lipid metabolism and fat distribution in patients with primary hyperparathyroidism and their Mendelian randomization study","volume":"88","author":"Zhang","year":"2025","journal-title":"Endocrine"},{"issue":"1","key":"2026021918532649300_dgaf625-B45","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12902-023-01302-9","article-title":"Primary hyperparathyroidism in young patients is associated with metabolic disorders: a prospective comparative study","volume":"23","author":"Bibik","year":"2023","journal-title":"BMC Endocr Disord"},{"issue":"7","key":"2026021918532649300_dgaf625-B46","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.3390\/jcm14072402","article-title":"Developmental trends of metabolic syndrome in the past two decades: a narrative review","volume":"14","author":"Obeidat","year":"2025","journal-title":"J Clin Med"},{"issue":"3","key":"2026021918532649300_dgaf625-B47","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1210\/jc.2004-1891","article-title":"Association between primary hyperparathyroidism and increased body weight: a meta-analysis","volume":"90","author":"Bolland","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"5-6","key":"2026021918532649300_dgaf625-B48","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0306-9877(03)00227-5","article-title":"PTH excess may promote weight gain by impeding catecholamine-induced lipolysis\u2014implications for the impact of calcium, vitamin D, and alcohol on body weight","volume":"61","author":"McCarty","year":"2003","journal-title":"Med Hypotheses"},{"issue":"6","key":"2026021918532649300_dgaf625-B49","doi-asserted-by":"crossref","first-page":"e20481","DOI":"10.1371\/journal.pone.0020481","article-title":"Primary hyperparathyroidism influences the expression of inflammatory and metabolic genes in adipose tissue","volume":"6","author":"Christensen","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"2026021918532649300_dgaf625-B50","first-page":"56","article-title":"The impact of vitamin D deficiency on clinical, biochemical and metabolic parameters in primary hyperparathyroidism","volume":"70","author":"\u015eeng\u00fcl Ay\u00e7i\u00e7ek","year":"2023","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)"},{"issue":"9","key":"2026021918532649300_dgaf625-B51","first-page":"841","article-title":"Prevalence and characteristics of metabolic syndrome in primary hyperparathyroidism","volume":"35","author":"Tassone","year":"2012","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2026021918532649300_dgaf625-B52","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12902-015-0014-5","article-title":"High prevalence of metabolic syndrome in a mestizo group of adult patients with primary hyperparathyroidism (PHPT)","volume":"15","author":"Mendoza-Zubieta","year":"2015","journal-title":"BMC Endocr Disord"},{"issue":"6","key":"2026021918532649300_dgaf625-B53","first-page":"548","article-title":"Prevalence of cardiovascular risk factors in male and female patients with primary hyperparathyroidism","volume":"35","author":"Han","year":"2012","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"2026021918532649300_dgaf625-B54","doi-asserted-by":"crossref","first-page":"584","DOI":"10.4158\/EP10321.OR","article-title":"Effects of successful parathyroidectomy on metabolic cardiovascular risk factors in patients with severe primary hyperparathyroidism","volume":"17","author":"Ishay","year":"2011","journal-title":"Endocr Pract"},{"issue":"8","key":"2026021918532649300_dgaf625-B55","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1530\/EC-18-0259","article-title":"The effect of surgery on fat mass, lipid and glucose metabolism in mild primary hyperparathyroidism","volume":"7","author":"Godang","year":"2018","journal-title":"Endocr Connect"},{"issue":"7","key":"2026021918532649300_dgaf625-B56","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1210\/jc.2008-2742","article-title":"Effect of surgery on cardiovascular risk factors in mild primary hyperparathyroidism","volume":"94","author":"Bollerslev","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026021918532649300_dgaf625-B57","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.metabol.2006.08.019","article-title":"Circulating leptin and adiponectin levels in patients with primary hyperparathyroidism","volume":"56","author":"Delfini","year":"2007","journal-title":"Metabolism"},{"issue":"4","key":"2026021918532649300_dgaf625-B58","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/BF03345719","article-title":"Cardiovascular risk factors in primary hyperparathyroidism","volume":"32","author":"Luboshitzky","year":"2009","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"2026021918532649300_dgaf625-B59","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s12020-013-0091-z","article-title":"Cardiovascular risk and metabolic syndrome in primary hyperparathyroidism and their correlation to different clinical forms","volume":"47","author":"Procopio","year":"2014","journal-title":"Endocrine"},{"key":"2026021918532649300_dgaf625-B60","doi-asserted-by":"crossref","first-page":"408295","DOI":"10.1155\/2012\/408295","article-title":"Arterial hypertension, metabolic syndrome and subclinical cardiovascular organ damage in patients with asymptomatic primary hyperparathyroidism before and after parathyroidectomy: preliminary results","volume":"2012","author":"Luigi","year":"2012","journal-title":"Int J Endocrinol"},{"issue":"1","key":"2026021918532649300_dgaf625-B61","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1530\/eje.1.02173","article-title":"Metabolic abnormalities in patients with normocalcemic hyperparathyroidism detected at a population-based screening","volume":"155","author":"Hagstr\u00f6m","year":"2006","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2026021918532649300_dgaf625-B62","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1530\/EJE-09-1067","article-title":"Cardiovascular risk factors and arterial rigidity are similar in asymptomatic normocalcemic and hypercalcemic primary hyperparathyroidism","volume":"162","author":"Tordjman","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"2026021918532649300_dgaf625-B63","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.3390\/nu12113522","article-title":"Improving glucose homeostasis after parathyroidectomy for normocalcemic primary hyperparathyroidism with co-existing prediabetes","volume":"12","author":"Karras","year":"2020","journal-title":"Nutrients"},{"key":"2026021918532649300_dgaf625-B64","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jss.2019.07.019","article-title":"Rising glucagon-like peptide 1 concentrations after parathyroidectomy in patients with primary hyperparathyroidism","volume":"245","author":"Antonopoulou","year":"2020","journal-title":"J Surg Res"},{"issue":"3","key":"2026021918532649300_dgaf625-B65","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s12020-014-0263-5","article-title":"Investigation of glucose intolerance in patients with normocalcemic primary hyperparathyroidism: 4-year follow-up","volume":"47","author":"Diri","year":"2014","journal-title":"Endocrine"},{"key":"2026021918532649300_dgaf625-B66","doi-asserted-by":"crossref","first-page":"107985","DOI":"10.1016\/j.diabres.2019.107985","article-title":"Increased parathyroid hormone is associated with higher fasting glucose in individuals with normocalcemic primary hyperparathyroidism and prediabetes: a pilot study","volume":"160","author":"Karras","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"2026021918532649300_dgaf625-B67","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/aje\/kws002","article-title":"Hyperuricemia in young adults and risk of insulin resistance, prediabetes, and diabetes: a 15-year follow-up study","volume":"176","author":"Krishnan","year":"2012","journal-title":"Am J Epidemiol"},{"issue":"1","key":"2026021918532649300_dgaf625-B68","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12872-025-04529-7","article-title":"The new definition of metabolic syndrome including hyperuricemia improves its prognostic value: results from NHANES database","volume":"25","author":"Zhang","year":"2025","journal-title":"BMC Cardiovasc Disord"},{"issue":"2","key":"2026021918532649300_dgaf625-B69","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/1756-185X.13740","article-title":"Primary hyperparathyroidism is associated with a higher level of serum uric acid: a systematic review and metaanalysis","volume":"23","author":"Ponvilawan","year":"2020","journal-title":"Int J Rheum Dis"},{"issue":"7","key":"2026021918532649300_dgaf625-B70","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1161\/ATVBAHA.113.303062","article-title":"Plasma-parathyroid hormone is associated with subclinical and clinical atherosclerotic disease in 2 community-based cohorts","volume":"34","author":"Hagstr\u00f6m","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"2026021918532649300_dgaf625-B71","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/cen.13418","article-title":"Is primary hyperparathyroidism a cause of endothelial dysfunction?","volume":"87","author":"Colak","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2026021918532649300_dgaf625-B72","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0008-6363(00)00130-9","article-title":"Impaired flow mediated vasodilation of the brachial artery in patients with primary hyperparathyroidism improves after parathyroidectomy","volume":"47","author":"Kosch","year":"2000","journal-title":"Cardiovasc Res"},{"issue":"6","key":"2026021918532649300_dgaf625-B73","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1067\/msy.2099.101422","article-title":"Endothelial vasodilatory dysfunction in primary hyperparathyroidism is reversed after parathyroidectomy","volume":"126","author":"Nilsson","year":"1999","journal-title":"Surgery"},{"issue":"7","key":"2026021918532649300_dgaf625-B74","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/BF03346518","article-title":"Endothelial function and endothelial nitric oxide synthase intron 4a\/b polymorphism in primary hyperparathyroidism","volume":"32","author":"Ekmekci","year":"2009","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"2026021918532649300_dgaf625-B75","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1365-2265.2000.01076.x","article-title":"Effects of successful parathyroidectomy on altered arterial reactivity in patients with hypercalcaemia: results of a 3-year follow-up study","volume":"53","author":"Neunteufl","year":"2000","journal-title":"Clin Endocrinol"},{"issue":"6","key":"2026021918532649300_dgaf625-B76","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.surg.2013.06.047","article-title":"Cardiovascular dysfunction in symptomatic primary hyperparathyroidism and its reversal after curative parathyroidectomy: results of a prospective case control study","volume":"154","author":"Agarwal","year":"2013","journal-title":"Surgery"},{"issue":"8","key":"2026021918532649300_dgaf625-B77","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1210\/jc.2013-4273","article-title":"Hemodynamic markers and subclinical atherosclerosis in postmenopausal women with primary hyperparathyroidism","volume":"99","author":"Stamatelopoulos","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2026021918532649300_dgaf625-B78","doi-asserted-by":"crossref","first-page":"e3745","DOI":"10.1210\/clinem\/dgaf138","article-title":"Platelet function and markers of atherothrombotic risk in subjects with parathyroid disorders: a cross-sectional study","volume":"110","author":"Naciu","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"2026021918532649300_dgaf625-B79","doi-asserted-by":"crossref","first-page":"e240124","DOI":"10.20945\/2359-4292-2024-0124","article-title":"Effect of parathyroidectomy on serum inflammatory and metabolic dysfunction markers in patients with primary hyperparathyroidism","volume":"68","author":"Deniz","year":"2024","journal-title":"Arch Endocrinol Metab"},{"issue":"1","key":"2026021918532649300_dgaf625-B80","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.eprac.2024.10.005","article-title":"Parathyroidectomy reduces inflammatory cytokines and increases vitamin d metabolites in patients with primary hyperparathyroidism","volume":"31","author":"Meng","year":"2025","journal-title":"Endocr Pract"},{"issue":"3","key":"2026021918532649300_dgaf625-B81","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/ejendo\/lvae109","article-title":"No effect of surgery on kidney and cardiovascular risk factors in mild primary hyperparathyroidism: secondary analyses from a 10-year randomized controlled trial","volume":"191","author":"Heck","year":"2024","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2026021918532649300_dgaf625-B82","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.surg.2015.07.037","article-title":"A pilot study investigating the effect of parathyroidectomy on arterial stiffness and coronary artery calcification in patients with primary hyperparathyroidism","volume":"159","author":"Dural","year":"2016","journal-title":"Surgery"},{"issue":"6","key":"2026021918532649300_dgaf625-B83","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/cen.12666","article-title":"Impaired endothelial function in patients with mild primary hyperparathyroidism improves after parathyroidectomy","volume":"83","author":"Tuna","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2026021918532649300_dgaf625-B84","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1365-2265.2012.04485.x","article-title":"Endothelial function in mild primary hyperparathyroidism","volume":"78","author":"Carrelli","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2026021918532649300_dgaf625-B85","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s10554-006-9166-8","article-title":"Impairment of flow mediated vasodilatation of brachial artery in patients with primary hyperparathyroidism","volume":"23","author":"Baykan","year":"2007","journal-title":"Int J Cardiovasc Imaging"},{"issue":"6","key":"2026021918532649300_dgaf625-B86","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1210\/jc.2004-1400","article-title":"Arterial stiffness in mild primary hyperparathyroidism","volume":"90","author":"Rubin","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2026021918532649300_dgaf625-B87","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1210\/jcem.85.10.6880","article-title":"Augmentation of central arterial pressure in mild primary hyperparathyroidism","volume":"85","author":"Smith","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026021918532649300_dgaf625-B88","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.atherosclerosis.2011.05.010","article-title":"Large-artery stiffness: a reversible marker of cardiovascular risk in primary hyperparathyroidism","volume":"218","author":"Schillaci","year":"2011","journal-title":"Atherosclerosis"},{"issue":"1","key":"2026021918532649300_dgaf625-B89","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/cen.12952","article-title":"Parathyroidectomy in asymptomatic primary hyperparathyroidism reduces carotid intima-media thickness and arterial stiffness","volume":"84","author":"Cansu","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2026021918532649300_dgaf625-B90","doi-asserted-by":"crossref","first-page":"16521","DOI":"10.1038\/s41598-018-35017-y","article-title":"Retinal micro-vascular and aortic macro-vascular changes in postmenopausal women with primary hyperparathyroidism","volume":"8","author":"Pepe","year":"2018","journal-title":"Sci Rep"},{"issue":"4","key":"2026021918532649300_dgaf625-B91","doi-asserted-by":"crossref","first-page":"248","DOI":"10.7326\/0003-4819-140-4-200402170-00006","article-title":"Retinal arteriolar diameters and risk of hypertension","volume":"140","author":"Wong","year":"2004","journal-title":"Ann Intern Med"},{"issue":"4","key":"2026021918532649300_dgaf625-B92","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4274\/tjh.2015.0087","article-title":"The effect of hyperparathyroid state on platelet functions and bone loss","volume":"33","author":"Yorulmaz","year":"2016","journal-title":"Turk J Haematol"},{"issue":"4","key":"2026021918532649300_dgaf625-B93","doi-asserted-by":"crossref","first-page":"182","DOI":"10.4149\/endo_2014_04_182","article-title":"Assessment of mean platelet volume (MPV) in primary hyperparathyroidism: effects of successful parathyroidectomy on MPV levels","volume":"48","author":"Yilmaz","year":"2014","journal-title":"Endocr Regul"},{"issue":"1","key":"2026021918532649300_dgaf625-B94","doi-asserted-by":"crossref","first-page":"19208","DOI":"10.1038\/s41598-020-76167-2","article-title":"Evaluation of coagulation parameters in patients with parathyroid adenoma","volume":"10","author":"Alay","year":"2020","journal-title":"Sci Rep"},{"issue":"2","key":"2026021918532649300_dgaf625-B95","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s11239-023-02906-7","article-title":"The calcium-clot connection: investigating the association between primary hyperparathyroidism and acute venous thromboembolism","volume":"57","author":"Khattar","year":"2024","journal-title":"J Thromb Thrombolysis"},{"issue":"5","key":"2026021918532649300_dgaf625-B96","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1530\/EJE-09-0069","article-title":"Increased plasma activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels in patients with primary hyperparathyroidism","volume":"160","author":"Erem","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"2026021918532649300_dgaf625-B97","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1055\/s-2008-1065365","article-title":"Blood coagulation; fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-dimer levels","volume":"116","author":"Erem","year":"2008","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2026021918532649300_dgaf625-B98","first-page":"CR628","article-title":"Biomarkers of hypercoagulability and inflammation in primary hyperparathyroidism","volume":"14","author":"Chertok-Shacham","year":"2008","journal-title":"Med Sci Monit"},{"key":"2026021918532649300_dgaf625-B99","first-page":"1547","article-title":"Effects of extracellular calcium concentration on platelets aggregation, coagulation indices and thromboelastography","volume":"90","author":"Li","year":"2010","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"6","key":"2026021918532649300_dgaf625-B100","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.3906\/sag-2012-247","article-title":"Akalin A, etal effect of hyperparathyroidism on coagulation: a global assessment by modified rotation thromboelastogram (ROTEM)","volume":"51","author":"Yorulmaz","year":"2021","journal-title":"Turk J Med Sci"},{"issue":"1","key":"2026021918532649300_dgaf625-B101","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jocd.2012.11.008","article-title":"Nontraditional manifestations of primary hyperparathyroidism","volume":"16","author":"Walker","year":"2013","journal-title":"J Clin Densitom"},{"issue":"43","key":"2026021918532649300_dgaf625-B102","doi-asserted-by":"crossref","first-page":"e7255","DOI":"10.1097\/MD.0000000000007255","article-title":"Echocardiogram changes following parathyroidectomy for primary hyperparathyroidism: a systematic review and meta-analysis","volume":"96","author":"Best","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"2026021918532649300_dgaf625-B103","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s40618-021-01645-x","article-title":"Cardiac structural and functional abnormalities in primary hyperparathyroidism","volume":"45","author":"Purra","year":"2022","journal-title":"J Endocrinol Invest"},{"issue":"9-10","key":"2026021918532649300_dgaf625-B104","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00508-017-1186-y","article-title":"Evaluation of left ventricular functions in patients with primary hyperparathyroidism: is there any effect of parathyroidectomy?","volume":"129","author":"Kepez","year":"2017","journal-title":"Wien Klin Wochenschr"},{"key":"2026021918532649300_dgaf625-B105","doi-asserted-by":"crossref","first-page":"1083521","DOI":"10.3389\/fendo.2023.1083521","article-title":"The preliminary study on cardiac structure and function in Chinese patients with primary hyperparathyroidism","volume":"14","author":"Chen","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"2026021918532649300_dgaf625-B106","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/cen.15210","article-title":"Curative parathyroidectomy in primary hyperparathyroidism improves both systolic and diastolic cardiac dysfunction: a six-month follow-up study at a tertiary care hospital","volume":"102","author":"Qadir","year":"2025","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2026021918532649300_dgaf625-B107","first-page":"e33429","article-title":"Effect of parathyroidectomy on left ventricular mass index in patients with primary hyperparathyroidism","volume":"1","author":"Tzikos","year":"2023","journal-title":"Cureus"},{"issue":"5","key":"2026021918532649300_dgaf625-B108","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/echo.14660","article-title":"The effect of successful parathyroid surgery on left ventricle function in patients with primary hyperparathyroidism evaluated with strain echocardiography","volume":"37","author":"Atasever","year":"2020","journal-title":"Echocardiography"},{"issue":"5","key":"2026021918532649300_dgaf625-B109","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/wjs.12104","article-title":"Assessment of left ventricular dysfunction by strain echo in primary hyperparathyroidism and its reversal after parathyroidectomy","volume":"48","author":"Pk","year":"2024","journal-title":"World J Surg"},{"key":"2026021918532649300_dgaf625-B110","doi-asserted-by":"crossref","first-page":"1163877","DOI":"10.3389\/fendo.2023.1163877","article-title":"Improvement of hypertension control and left-ventricular function after cure of primary hyperparathyroidism","volume":"14","author":"Karwacka","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"2026021918532649300_dgaf625-B111","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1515\/cclm-2016-1159","article-title":"Low-grade inflammation and tryptophan-kynurenine pathway activation are associated with adverse cardiac remodeling in primary hyperparathyroidism: the EPATH trial","volume":"55","author":"Verheyen","year":"2017","journal-title":"Clin Chem Lab Med"},{"issue":"4","key":"2026021918532649300_dgaf625-B112","doi-asserted-by":"crossref","first-page":"e0173799","DOI":"10.1371\/journal.pone.0173799","article-title":"Relationship between bone turnover and left ventricular function in primary hyperparathyroidism: the EPATH trial","volume":"12","author":"Verheyen","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"2026021918532649300_dgaf625-B113","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1530\/EJE-10-0201","article-title":"Cardiac function in mild primary hyperparathyroidism and the outcome after parathyroidectomy","volume":"163","author":"Farahnak","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2026021918532649300_dgaf625-B114","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1210\/jc.2009-2072","article-title":"Cardiac structure and diastolic function in mild primary hyperparathyroidism","volume":"95","author":"Walker","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026021918532649300_dgaf625-B115","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1365-2265.2010.03909.x","article-title":"Effect of surgery on cardiac structure and function in mild primary hyperparathyroidism","volume":"74","author":"Persson","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2026021918532649300_dgaf625-B116","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s12020-014-0245-7","article-title":"Evaluation of left ventricle functions by tissue doppler, strain, and strain rate echocardiography in patients with primary hyperparathyroidism","volume":"47","author":"Ozdemir","year":"2014","journal-title":"Endocrine"},{"key":"2026021918532649300_dgaf625-B117","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.2147\/CIA.S244063","article-title":"Calcification of cardiac valves in metabolic bone disease: an updated review of clinical studies","volume":"15","author":"Carrai","year":"2020","journal-title":"Clin Interv Aging"},{"issue":"1","key":"2026021918532649300_dgaf625-B118","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1210\/jc.2011-2107","article-title":"Aortic valve calcification in mild primary hyperparathyroidism","volume":"97","author":"Iwata","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2026021918532649300_dgaf625-B119","doi-asserted-by":"crossref","first-page":"bvad081","DOI":"10.1210\/jendso\/bvad081","article-title":"Periostin in osteoporosis and cardiovascular disease","volume":"7","author":"Pickering","year":"2023","journal-title":"J Endocr Soc"},{"issue":"11","key":"2026021918532649300_dgaf625-B120","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1007\/s00198-021-06018-x","article-title":"Higher serum levels of a cathepsin K-generated periostin fragment are associated with fractures in postmenopausal women with primary hyperparathyroidism: a pilot study","volume":"32","author":"Pepe","year":"2021","journal-title":"Osteoporos Int"},{"issue":"2","key":"2026021918532649300_dgaf625-B121","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2174\/0115701611280905231227045826","article-title":"Hyperparathyroidism and peripheral arterial disease","volume":"22","author":"Antignani","year":"2024","journal-title":"Curr Vasc Pharmacol"},{"key":"2026021918532649300_dgaf625-B122","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1530\/eje.0.1470453","article-title":"Increased intima-media thickness of the carotid artery wall, normal blood pressure profile and normal left ventricular mass in subjects with primary hyperparathyroidism","volume":"147","author":"Nuzzo","year":"2002","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2026021918532649300_dgaf625-B123","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.55730\/1300-0144.5405","article-title":"Evaluation of subclinical cardiovascular disease by carotid intima media thickness, epicardial adipose tissue thickness, serum endocan, and nesfatin-1 levels in patients with primary hyperparathyroidism","volume":"52","author":"Kocaba\u015f","year":"2022","journal-title":"Turk J Med Sci"},{"issue":"10","key":"2026021918532649300_dgaf625-B124","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1210\/jc.2009-1086","article-title":"Carotid vascular abnormalities in primary hyperparathyroidism","volume":"94","author":"Walker","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2026021918532649300_dgaf625-B125","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1210\/jc.2002-021837","article-title":"Ultrasound evaluation of carotid artery in primary hyperparathyroidism","volume":"88","author":"Fallo","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2026021918532649300_dgaf625-B126","first-page":"887","article-title":"Intima-media thickness measurement of the carotid artery in patients with primary hyperparathyroidism. A prospective case-control study and long-term follow-up","volume":"20","author":"Lumachi","year":"2006","journal-title":"In Vivo"},{"issue":"7","key":"2026021918532649300_dgaf625-B127","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0895-7061(00)00248-X","article-title":"Studies on flow-mediated vasodilation and intima-media thickness of the brachial artery in patients with primary hyperparathyroidism","volume":"13","author":"Kosch","year":"2000","journal-title":"Am J Hypertens"},{"issue":"5","key":"2026021918532649300_dgaf625-B128","first-page":"1815","article-title":"Cardiovascular effects of parathyroid hormone: a study in healthy subjects and normotensive patients with mild primary hyperparathyroidism","volume":"85","author":"Barletta","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2026021918532649300_dgaf625-B129","first-page":"303","article-title":"Arterial distensibility and pulse wave velocity in patients with primary hyperparathyroidism before and after parathyroidectomy","volume":"55","author":"Kosch","year":"2001","journal-title":"Clin Nephrol"},{"issue":"12","key":"2026021918532649300_dgaf625-B130","doi-asserted-by":"crossref","first-page":"e2342","DOI":"10.1210\/clinem\/dgae053","article-title":"Carotid intima-media thickness in surgically or conservatively managed patients with primary hyperparathyroidism","volume":"109","author":"Carnevale","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026021918532649300_dgaf625-B131","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1530\/EJE-15-1152","article-title":"High prevalence of abdominal aortic calcification in patients with primary hyperparathyroidism as evaluated by Kauppila score","volume":"175","author":"Pepe","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2026021918532649300_dgaf625-B132","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1055\/a-0664-7820","article-title":"The abdominal aortic intima-media thickness increases in patients with primary hyperparathyroidism","volume":"127","author":"Sumbul","year":"2019","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2026021918532649300_dgaf625-B133","doi-asserted-by":"crossref","first-page":"1266728","DOI":"10.3389\/fendo.2023.1266728","article-title":"Cardiovascular and metabolic status in patients with primary hyperparathyroidism: a single-center experience","volume":"14","author":"Dobreva","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"2026021918532649300_dgaf625-B134","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1530\/EJE-12-0124","article-title":"Effect of parathyroidectomy on subclinical cardiovascular disease in mild primary hyperparathyroidism","volume":"167","author":"Walker","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2026021918532649300_dgaf625-B135","doi-asserted-by":"crossref","first-page":"67","DOI":"10.5603\/EP.a2023.0010","article-title":"B-mode ultrasound assessment of carotid artery structural features in patients with normocalcaemic hyperparathyroidism","volume":"74","author":"Elbuken","year":"2023","journal-title":"Endokrynol Pol"},{"issue":"13","key":"2026021918532649300_dgaf625-B136","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1245\/s10434-013-3187-z","article-title":"Presentation, management, and outcomes of hyperparathyroidism in octogenarians and nonagenarians","volume":"20","author":"Oltmann","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"2026021918532649300_dgaf625-B137","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4158\/EP.14.2.155","article-title":"Coronary artery calcification in patients with primary hyperparathyroidism in comparison with control subjects from the multi-ethnic study of atherosclerosis","volume":"14","author":"Streeten","year":"2008","journal-title":"Endocr Pract"},{"issue":"1","key":"2026021918532649300_dgaf625-B138","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.surg.2019.05.094","article-title":"Coronary artery disease is more severe in patients with primary hyperparathyroidism","volume":"167","author":"Koubaity","year":"2020","journal-title":"Surgery"},{"issue":"9","key":"2026021918532649300_dgaf625-B139","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1161\/CIRCULATIONAHA.111.081307","article-title":"Coronary microvascular dysfunction induced by primary hyperparathyroidism is restored after parathyroidectomy","volume":"126","author":"Osto","year":"2012","journal-title":"Circulation"},{"issue":"12","key":"2026021918532649300_dgaf625-B140","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1007\/s00259-010-1599-6","article-title":"Reduced coronary flow reserve in patients with primary hyperparathyroidism: a study by G-SPECT myocardial perfusion imaging","volume":"37","author":"Marini","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026021918532649300_dgaf625-B141","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000006508","article-title":"Effect of delayed parathyroidectomy on risk of future cardiovascular and nephrolithiasis interventions in adults with primary hyperparathyroidism","author":"Ramonell","year":"2024","journal-title":"Ann Surg"},{"issue":"2","key":"2026021918532649300_dgaf625-B142","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10554-008-9369-2","article-title":"Evaluation of subclinical coronary atherosclerosis in mild asymptomatic primary hyperparathyroidism patients","volume":"25","author":"Kepez","year":"2009","journal-title":"Int J Cardiovasc Imaging"},{"key":"2026021918532649300_dgaf625-B143","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2147\/VHRM.S128084","article-title":"Evaluation of coronary calcium score in patients with normocalcemic primary hyperparathyroidism","volume":"13","author":"Mesquita","year":"2017","journal-title":"Vasc Health Risk Manag"},{"issue":"2","key":"2026021918532649300_dgaf625-B144","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-0736(05)80092-5","article-title":"Serum calcium and the ECG in patients with primary hyperparathyroidism","volume":"27","author":"Lind","year":"1994","journal-title":"J of Electrocardiol"},{"issue":"2","key":"2026021918532649300_dgaf625-B145","doi-asserted-by":"crossref","first-page":"397","DOI":"10.55730\/1300-0144.5326","article-title":"Tp-e interval, Tp-e\/QT, and Tp-e\/QTc ratios in patients with primary hyperparathyroidism and their relationship with cardiac arrhythmic events","volume":"52","author":"Y\u0131lmaz","year":"2022","journal-title":"Turk J Med Sci"},{"issue":"4","key":"2026021918532649300_dgaf625-B146","doi-asserted-by":"crossref","first-page":"e1689","DOI":"10.1210\/clinem\/dgab820","article-title":"Primary hyperparathyroidism is associated with shorter qtc intervals, but not arrhythmia","volume":"107","author":"Stewart","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026021918532649300_dgaf625-B147","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/eci.12038","article-title":"Arrhythmias in primary hyperparathyroidism evaluated by exercise test","volume":"43","author":"Pepe","year":"2013","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"2026021918532649300_dgaf625-B148","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1530\/EJE-13-0293","article-title":"Parathyroidectomy eliminates arrhythmic risk in primary hyperparathyroidism, as evaluated by exercise test","volume":"169","author":"Pepe","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2026021918532649300_dgaf625-B149","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2265.2011.04169.x","article-title":"Adrenergic and cardiac dysfunction in primary hyperparathyroidism","volume":"76","author":"Birgander","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2026021918532649300_dgaf625-B150","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ijcard.2006.08.072","article-title":"Increased risk of cardiac death in primary hyperparathyroidism: what is a role of electrical instability?","volume":"121","author":"Curione","year":"2007","journal-title":"Int J Cardiol"},{"issue":"2","key":"2026021918532649300_dgaf625-B151","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijcard.2008.11.067","article-title":"Parathyroidectomy erase increased myocardial electrical vulnerability in patients with primary hyperparathyroidism","volume":"141","author":"Curione","year":"2010","journal-title":"Int J Cardiol"},{"issue":"2","key":"2026021918532649300_dgaf625-B152","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1530\/EJE-17-0948","article-title":"Reduction of arrhythmias in primary hyperparathyroidism, by parathyroidectomy, evaluated with 24-h ECG monitoring","volume":"179","author":"Pepe","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"19","key":"2026021918532649300_dgaf625-B153","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1001\/archinternmed.2011.433","article-title":"QT-interval duration and mortality rate: results from the Third National Health and Nutrition Examination Survey","volume":"171","author":"Zhang","year":"2011","journal-title":"Arch Int Med"},{"issue":"5","key":"2026021918532649300_dgaf625-B154","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ahj.2013.02.014","article-title":"Parathyroid hormone and cardiovascular disease events: a systematic review and meta-analysis of prospective studies","volume":"165","author":"van Ballegooijen","year":"2013","journal-title":"Am Heart J"},{"issue":"6","key":"2026021918532649300_dgaf625-B155","doi-asserted-by":"crossref","first-page":"e2215396","DOI":"10.1001\/jamanetworkopen.2022.15396","article-title":"Analysis of comorbidities, clinical outcomes, and parathyroidectomy in adults with primary hyperparathyroidism","volume":"5","author":"Axelsson","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"6","key":"2026021918532649300_dgaf625-B156","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1097\/SLA.0000000000005999","article-title":"Parathyroidectomy and the risk of major cerebrovascular and cardiovascular events in the elderly","volume":"278","author":"Grant","year":"2023","journal-title":"Ann Surg"},{"issue":"1","key":"2026021918532649300_dgaf625-B157","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1080\/00365513.2019.1683763","article-title":"Hyperparathyroidism in men\u2014morbidity and mortality during 21 years\u2019 follow-up","volume":"80","author":"Kontogeorgos","year":"2020","journal-title":"Scand J Clin Lab Invest"},{"key":"2026021918532649300_dgaf625-B158","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/bs.afnr.2023.12.005","article-title":"Vitamin D and cardiovascular diseases","volume":"109","author":"Milazzo","year":"2024","journal-title":"Adv Food Nutr Res"},{"issue":"9","key":"2026021918532649300_dgaf625-B159","doi-asserted-by":"crossref","first-page":"e842","DOI":"10.1210\/clinem\/dgad103","article-title":"Morbidity associated with primary hyperparathyroidism-a population-based study with a subanalysis on vitamin D","volume":"108","author":"Soto-Pedre","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"2026021918532649300_dgaf625-B160","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.amjcard.2024.03.003","article-title":"Unveiling the hidden stroke threat in patients with atrial fibrillation and primary hyperparathyroidism","volume":"218","author":"Khattar","year":"2024","journal-title":"Am J Cardiol"},{"key":"2026021918532649300_dgaf625-B161","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bone.2014.12.067","article-title":"Mortality associated with primary hyperparathyroidism","volume":"74","author":"Clifton-Bligh","year":"2015","journal-title":"Bone"},{"issue":"1","key":"2026021918532649300_dgaf625-B162","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2265.2009.03766.x","article-title":"Increased mortality and morbidity in mild primary hyperparathyroid patients. The parathyroid epidemiology and audit research study (PEARS)","volume":"73","author":"Yu","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2026021918532649300_dgaf625-B163","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0002-9343(97)00270-2","article-title":"Survival after the diagnosis of hyperparathyroidism: a population-based study","volume":"104","author":"Wermers","year":"1998","journal-title":"Am J Med"},{"issue":"6","key":"2026021918532649300_dgaf625-B164","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0039-6060(97)90216-6","article-title":"Survival after surgical treatment for primary hyperparathyroidism","volume":"122","author":"Soreide","year":"1997","journal-title":"Surgery"},{"issue":"7","key":"2026021918532649300_dgaf625-B165","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1093\/bjs\/znab017","article-title":"Mortality after surgery for primary hyperparathyroidism: results from a nationwide cohort","volume":"108","author":"Nilsson","year":"2021","journal-title":"Br J Surg"},{"issue":"2","key":"2026021918532649300_dgaf625-B166","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1530\/EJE-08-0523","article-title":"Postoperative mortality in parathyroid surgery in Sweden during five decades: improved outcome despite older patients","volume":"160","author":"Norenstedt","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2026021918532649300_dgaf625-B167","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s00268-002-6541-z","article-title":"Cardiovascular events before and after surgery for primary hyperparathyroidism","volume":"27","author":"Vestergaard","year":"2003","journal-title":"World J Surg"},{"issue":"1","key":"2026021918532649300_dgaf625-B168","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1365-2362.1995.tb01525.x","article-title":"Clinical evaluation of total serum calcium in primary hyperparathyroidism and the risk of death after surgery","volume":"25","author":"Hedb\u00e4ck","year":"1995","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"2026021918532649300_dgaf625-B169","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2265.2009.03766.x","article-title":"What predicts adverse outcomes in untreated primary hyperparathyroidism? The parathyroid epidemiology and audit research study (PEARS)","volume":"73","author":"Yu","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2026021918532649300_dgaf625-B170","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1067\/msy.2001.118377","article-title":"Increased cardiovascular mortality and normalized serum calcium in patients with mild hypercalcemia followed up for 25 years","volume":"130","author":"Lundgren","year":"2001","journal-title":"Surgery"},{"issue":"4","key":"2026021918532649300_dgaf625-B171","doi-asserted-by":"crossref","first-page":"95","DOI":"10.14740\/jem573","article-title":"Primary hyperparathyroidism: comparing cardiovascular morbidity and mortality in patients treated with parathyroidectomy versus conservative management","volume":"9","author":"Nana","year":"2019","journal-title":"J Endocrinol Metab"},{"issue":"1","key":"2026021918532649300_dgaf625-B172","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s12020-022-03211-8","article-title":"Residual risks of comorbidities after parathyroidectomy in a nationwide cohort of patients with primary hyperparathyroidism","volume":"79","author":"Kong","year":"2023","journal-title":"Endocrine"},{"issue":"6","key":"2026021918532649300_dgaf625-B173","doi-asserted-by":"crossref","first-page":"812","DOI":"10.7326\/M21-4416","article-title":"Mortality and morbidity in mild primary hyperparathyroidism: results from a 10-year prospective randomized controlled trial of parathyroidectomy versus observation","volume":"175","author":"Pretorius","year":"2022","journal-title":"Ann Intern Med"},{"issue":"1","key":"2026021918532649300_dgaf625-B174","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.eprac.2021.09.005","article-title":"Association of serum parathyroid hormone levels with all-cause and cause-specific mortality among U.S. adults","volume":"28","author":"Kato","year":"2022","journal-title":"Endocr Pract"},{"issue":"1","key":"2026021918532649300_dgaf625-B175","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0021-9258(18)84804-9","article-title":"Further studies on the physiological action of parathyroid hormone","volume":"64","author":"Collip","year":"1925","journal-title":"J Biol Chem"},{"issue":"2","key":"2026021918532649300_dgaf625-B176","first-page":"123","article-title":"Effect of gender and geographic location on the expression of primary hyperparathyroidism","volume":"36","author":"De Lucia","year":"2013","journal-title":"J Endocrinol Invest"},{"issue":"8","key":"2026021918532649300_dgaf625-B177","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S2213-8587(16)00076-0","article-title":"Explaining geographical variation in the presentation of primary hyperparathyroidism","volume":"4","author":"Minisola","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"2026021918532649300_dgaf625-B178","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4158\/EP15951.OR","article-title":"Impact of ethnic background on clinical characteristics and cardiovascular risk factors among patients with primary hyperparathyroidism","volume":"22","author":"Hu","year":"2016","journal-title":"Endocr Pract"},{"key":"2026021918532649300_dgaf625-B179","first-page":"40","article-title":"Sporadic and hereditary primary hyperparathyroidism","volume":"34","author":"Pepe","year":"2011","journal-title":"J Endocrinol Invest"},{"issue":"8","key":"2026021918532649300_dgaf625-B180","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1359\/jbmr.090304","article-title":"Sporadic and MEN1-related primary hyperparathyroidism: differences in clinical expression and severity","volume":"24","author":"Eller-Vainicher","year":"2009","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2026021918532649300_dgaf625-B181","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/s12020-023-03476-7","article-title":"Genetic aspects underlying the normocalcemic and hypercalcemic phenotypes of primary hyperparathyroidism","volume":"82","author":"Viviani","year":"2023","journal-title":"Endocrine"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaf625\/65293051\/dgaf625.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/3\/603\/65293051\/dgaf625.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/3\/603\/65293051\/dgaf625.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T23:53:57Z","timestamp":1771545237000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/111\/3\/603\/8323601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":181,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,11,14]]},"published-print":{"date-parts":[[2026,2,20]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaf625","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2025,11,14]]}}}